Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
Huntington’s disease (HD) is an inherited, autosomal dominant, degenerative disease characterized by involuntary movements, cognitive decline, and behavioral impairment ending in death. HD is caused by an expansion in the number of CAG repeats in the huntingtin gene on chromosome 4. To dat...
Main Authors: | Maria Csobonyeiova, Stefan Polak, Lubos Danisovic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/6/2239 |
Similar Items
-
iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01) -
A platform for studies of Huntington’s disease on the basis of induced pluripotent stem cells
by: E. D. Nekrasov, et al.
Published: (2017-02-01) -
iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review
by: Maria Csobonyeiova, et al.
Published: (2017-07-01) -
Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease
by: Raleigh M. Linville, et al.
Published: (2022-06-01) -
Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
by: Sahar Avazzadeh, et al.
Published: (2021-03-01)